Product Detail


Share to:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Cas No. 855778-84-6, 3-(piperidin-4-yl)quinolin-2(1h)-one hydrochloride

  • 855778-84-6

  • C14H17ClN2O

  • 264.75

  • 0.992

  • 98% min (HPLC)

  • 113.2

  • Light yellow powder

  • Migraine

  • Zavegepant

  • 10/7/2031 (Zavegepant)

  • CGRP

  • N

  • 2kg

  • 2023

  • ISO 9001

  • CDMO



Zavegepant offers a transformative approach to migraine treatment by targeting the underlying cause of migraine attacks. With its efficacy in reducing migraine severity and frequency, Zavegepant holds immense value in the field of neurology. Seamlessly incorporate our intermediates into your manufacturing process, ensuring a consistent supply of this exceptional medication. Join us in revolutionizing the management of migraines and improving the lives of millions of sufferers. Embrace Zavegepant and redefine the future of migraine therapy.

Product Description

A Witty reagent such as Trimethyl phosphonoacetate (CAS No. 5927-18-4) is used to synthesize this compound CAS No. 855778-84-6, followed by catalyzed hydrogenation.

synthesis of Zavegepant intermediate cas no 855778-84-6

CAS No. 855778-84-6 then reacts with CAS No. 1414976-14-9 to yield the N-1 Zavegepant intermediate.

final steps of Zavegepant synthesis